Literature DB >> 27706701

Analysis of FKBP10, SERPINH1, and SERPINF1 genes in patients with osteogenesis imperfecta.

C Barbirato1,2, M Trancozo3,4, M R G O Rebouças5, V Sipolatti5, V R R Nunes5, F Paula3,4.   

Abstract

Osteogenesis imperfecta (OI) is a heterogeneous disorder that causes fragility, deformity, and fractures in bones. A large number of genes that are associated with the disease have been identified in the last decade; this makes the genetic diagnosis of OI more difficult. To improve our knowledge of the genetic mutation profile in OI we used single-stranded conformation polymorphism screening and automated sequencing to investigate the SERPINH1, FKBP10, and SERPINF1 genes, which are related to recessive OI, in 23 unrelated Brazilian patients. Nine rare changes and four common polymorphisms were detected. Most changes were benign genetic variants. In general, changes in the SERPINH1 and SERPINF1 genes were synonymous polymorphisms or missense changes located in non-coding regions. A pathogenic change was found in the FKBP10 gene. The characterization of mutations related to OI in distinct populations can improve our knowledge of the genetic aspects of OI and help us develop molecular strategies for the diagnosis of the disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27706701     DOI: 10.4238/gmr.15038665

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  3 in total

1.  Health-related quality of life in children with osteogenesis imperfecta: a large-sample study.

Authors:  Y Song; D Zhao; L Li; F Lv; O Wang; Y Jiang; W Xia; X Xing; M Li
Journal:  Osteoporos Int       Date:  2018-12-19       Impact factor: 4.507

2.  Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.

Authors:  Y Song; D Zhao; X Xu; F Lv; L Li; Y Jiang; O Wang; W Xia; X Xing; M Li
Journal:  Osteoporos Int       Date:  2018-03-09       Impact factor: 4.507

3.  Osteogenesis imperfecta in Brazilian patients.

Authors:  Maira Trancozo; Marcos V D Moraes; Dalila A Silva; Jéssica A M Soares; Clara Barbirato; Márcio G Almeida; Lígia R Santos; Maria R G O Rebouças; Akel N Akel; Valentim Sipolatti; Vanda R R Nunes; Flavia I V Errera; Meire Aguena; Maria R Passos-Bueno; Flavia de Paula
Journal:  Genet Mol Biol       Date:  2019-08-15       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.